Apart from the proposed ongoing new therapeutic solutions for CD (including genetically modified gluten, zonulin inhibitors, therapeutic vaccines, and tissue transglutaminase inhibitors), probiotics appear to be a practical, integrative therapeutic approach to CD management along with a gluten-free diet [38]. The gene discussed is TGM2; the disease is Cowden disease.